Back
Aclaris Therapeutics Stock Price Chart
He cracked the code to crypto
Now he says a new two-year bull market has begun. And he likes one altcoin above all others.
Sell
26
ACRS
Aclaris Therapeutics
Last Price:
1.36
Seasonality Move:
-1.77%
7 Day Trial
ALL ACCESS PASS
$
7
The little-known AI stock you need to read about now...
Get the name - FREE.- Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ACRS is experiencing slight buying pressure.
Aclaris Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.24 | Buy |
| 20-day SMA: | 1.22 | Buy |
| 50-day SMA: | 1.23 | Buy |
| 200-day SMA: | 3.53 | Sell |
| 8-day EMA: | 1.27 | Buy |
| 20-day EMA: | 1.24 | Buy |
| 50-day EMA: | 1.26 | Buy |
| 200-day EMA: | 3.51 | Sell |
Aclaris Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.02 | Buy |
| Relative Strength Index (14 RSI): | 67.97 | Buy |
| Chaikin Money Flow: | 76464 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.19 - 1.27) | Buy |
| Bollinger Bands (100): | (1.08 - 1.28) | Buy |
Aclaris Therapeutics Technical Analysis
| Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 22 | 23 | 24 | 25 | 26 | 29 | 30 | 01 | 02 | 03 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Aclaris Therapeutics Stock
Is Aclaris Therapeutics Stock a Buy?
- Aclaris Therapeutics share price is 1.36 while ACRS 8-day simple moving average is 1.24, which is a Buy signal.
- The stock price of ACRS is 1.36 while Aclaris Therapeutics 20-day SMA is 1.22, which makes it a Buy.
- Aclaris Therapeutics 50-day simple moving average is 1.23 while ACRS share price is 1.36, making it a Buy technically.
- ACRS stock price is 1.36 and Aclaris Therapeutics 200-day simple moving average is 3.53, creating a Sell signal.
ACRS Technical Analysis vs Fundamental Analysis
Sell
26
Aclaris Therapeutics (ACRS)
is a Sell
Is Aclaris Therapeutics a Buy or a Sell?
-
Aclaris Therapeutics stock is rated a Sell
The current Aclaris Therapeutics [ACRS] share price is $1.36. The Score for ACRS is 26, which is 48% below its historic median score of 50, and infers higher risk than normal.
Aclaris Therapeutics Stock Info
Market Cap:
96.92M
Price in USD:
1.36
Share Volume:
688.17K
Aclaris Therapeutics 52-Week Range
52-Week High:
11.12
52-Week Low:
0.59
Sell
26
Aclaris Therapeutics (ACRS)
is a Sell
Aclaris Therapeutics Share Price Forecast
-
What is the Aclaris Therapeutics stock price today?
The Aclaris Therapeutics stock price is 1.36 USD today. -
Will ACRS stock go up or go down?
Aclaris Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Aclaris Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Aclaris Therapeutics is overvalued.
Is Aclaris Therapeutics Stock a Buy?
- Aclaris Therapeutics share price is 1.36 while ACRS 8-day exponential moving average is 1.27, which is a Buy signal.
- The stock price of ACRS is 1.36 while Aclaris Therapeutics 20-day EMA is 1.24, which makes it a Buy.
- Aclaris Therapeutics 50-day exponential moving average is 1.26 while ACRS share price is 1.36, making it a Buy technically.
- ACRS stock price is 1.36 and Aclaris Therapeutics 200-day simple moving average is 3.51, creating a Sell signal.
Fundamental Analysis of Aclaris Therapeutics
Is Aclaris Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $0.25 per share, an increase next quarter of $0.06 per share, an increase this year of $0.55 per share, and an increase next year of $0.30 per share.
Technical Analysis of Aclaris Therapeutics
Should I short Aclaris Therapeutics stock?
- ACRS Moving Average Covergence Divergence (MACD) indicator is 0.02, suggesting Aclaris Therapeutics is a Buy
- Aclaris Therapeutics Relative Strength Index (RSI) is 67.97, which suggest Aclaris Therapeutics is overbought
- The Bollinger Bands (25) for Aclaris Therapeutics is (1.19 - 1.27), which suggest Aclaris Therapeutics is a Buy
- The Bollinger Bands (100) for Aclaris Therapeutics is (1.08 - 1.28), which suggest Aclaris Therapeutics is a Buy
* Aclaris Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.